...
首页> 外文期刊>Frontiers in Microbiology >Isolation, Screening, and Identification of Novel Isolates of Actinomycetes from India for Antimicrobial Applications
【24h】

Isolation, Screening, and Identification of Novel Isolates of Actinomycetes from India for Antimicrobial Applications

机译:印度抗菌放线菌的新分离株的分离,筛选和鉴定

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The search for novel bioactive compounds from the natural environment has rapidly been gaining momentum with the increase in multi-drug resistant (MDR) pathogens. In the present study, the antimicrobial potential of novel actinomycetes has been evaluated by initial screening of six soil samples. Primary and secondary screening was performed against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Candida albicans, Candida tropicalis, Trichophyton rubrum , and other MDR bacterial and fungal test strains, thirteen active isolates were selected for further study. Microbial strains were identified on the basis of growth conditions and other biochemical characters. Five most active microbial strains were identified using 16S rRNA sequence homology and designated as Streptomyces xanthophaeus MTCC 11938, Streptomyces variabilis MTCC 12266, Streptomyces xanthochromogenes MTCC 11937, Streptomyces levis EU 124569, and Streptomyces sp. NCIM 5500. Four antibacterial and three antifungal compounds isolated from the above five isolates were purified and partially characterized using UV absorption and IR spectra. Two antibacterial metabolites, belong to chromone and peptide antibiotic, respectively. The antifungal compounds were found to be of non-polyene nature. In conclusion, we study the isolation of novel bacterial strains of actinomycetes for producing novel compounds having antibacterial and antifungal activities from the unexplored agro-ecological niches of India. Also, this study paves the way for further characterization of these isolates of Streptomyces sp. for their optimum utilization for antimicrobial purposes.
机译:随着耐多药病原体的增加,从自然环境中寻找新的生物活性化合物的势头迅速增强。在本研究中,已通过初步筛选六个土壤样品评估了新型放线菌的抗菌潜力。针对枯草芽孢杆菌,金黄色葡萄球菌,大肠杆菌,白色念珠菌,热带念珠菌,红毛癣菌和其他MDR细菌和真菌测试菌株进行了初次和二次筛选,选择了13个活性分离株用于进一步研究。根据生长条件和其他生化特征鉴定了微生物菌株。使用16S rRNA序列同源性鉴定了五个活性最高的微生物菌株,分别命名为xanthophaeus MTCC 11938,变异链霉菌MTCC 12266,xanthochromogenes MTCC 11937,levis链霉菌EU 124569和Streptomyces sp。 NCIM5500。从上述五个分离物中分离出的四种抗菌和三种抗真菌化合物经过纯化,并使用紫外吸收和红外光谱进行了部分表征。两种抗菌代谢物分别属于色酮和肽抗生素。发现抗真菌化合物具有非多烯性质。总之,我们研究了放线菌的新型细菌菌株的分离,用于从印度未开发的农业生态位中生产具有抗菌和抗真菌活性的新型化合物。同样,该研究为进一步鉴定链霉菌属的这些菌株铺平了道路。为抗菌目的提供最佳利用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号